SIM
ADVM

Spark Investment Management’s Adverum Biotechnologies ADVM Stock Holding History

Spark Investment Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,682
Closed -$233K – 598
2017
Q4 		$233K Buy
6,682
+2,612
+64% +$86K 0.01% 550
2017
Q3 		$148K Buy
+4,070
New +$113K 0.01% 633
2015
Q2 		– Sell
-750
Closed -$303K – 658
2015
Q1 		$303K Buy
750
+350
+88% +$148K 0.04% 462
2014
Q4 		$215K Sell
400
-1,050
-72% -$405K 0.04% 479
2014
Q3 		$495K Buy
+1,450
New +$431K 0.07% 352

Other funds holding ADVM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Spark Investment Management's ADVM Position: Q1 2018 in Review

Spark Investment Management sold out of Adverum Biotechnologies (ADVM) in Q1 2018, closing a stake of 6,682 shares — an estimated $233K sold.

Spark Investment Management first reported a position in ADVM in Q3 2014 and held it in 5 quarters. The position peaked at $495K in Q3 2014. 96 funds tracked by Wall St. Rank hold ADVM as of Q1 2018.

  • Spark Investment Management reported no remaining Adverum Biotechnologies position as of Q1 2018 after selling out during the quarter.
  • Spark Investment Management sold 6,682 Adverum Biotechnologies shares in Q1 2018, an estimated $233K.
  • Spark Investment Management first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 5 quarters.
  • Spark Investment Management's Adverum Biotechnologies position peaked at $495K in Q3 2014.
  • 96 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2018.

Based on Spark Investment Management's 13F filing for Q1 2018, filed 10 May 2018.